Netherlands· NL-c2abe5c9e03a
Aminoplasmal B. Braun 10% E-vrij, oplossing voor infusie
A aminosäuren product containing alanine, (l-) + arginine, (l-) + asparaginezuur, (l-) + fenylalanine, (l-), registered in Netherlands by B. Braun Melsungen AG (Melsungen). The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Aminosäuren is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Aminosäuren · ATC B05BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ALANINE, (L-) + ARGININE, (L-) + ASPARAGINEZUUR, (L-) + FENYLALANINE, (L-)
- Manufacturer
- B. Braun Melsungen AG (Melsungen)
- Country
- Netherlands (NL)
- ATC code
- B05BA01
- ATC class
- Aminosäuren
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id113028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for aminosäuren.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminosäuren · interactions on record
4 records
- 4 moderate
Most severe, free to view
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- MetamfetamineN06BA03moderate
- LisdexamfetamineN06BA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B05BA01
Aminosäuren, as other registers publish it.
- Canada20% PROSOLBAXTER CORPORATION
- FinlandAminessPfizer Health Ab
- PolandAminomix 1 NovumFresenius Kabi Deutschland GmbH
- FinlandAminoplasmalB. Braun Melsungen AG
- DenmarkAminoplasmalB. Braun Melsungen
- PolandAminoplasmal 15%B. Braun Melsungen AG
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aeba2a2a-d4e0-4f26-8b0d-284d59fcfcdb GET /v1/drugs/aeba2a2a-d4e0-4f26-8b0d-284d59fcfcdb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113028_smpc.pdf",
"strength": null,
"atc_label": "Amino Acids",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113028",
"excipients": [
"ACETYLCYSTEÏNE",
"CITROENZUUR 1-WATER (E 330)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"ALANINE, (L-)",
"ARGININE, (L-)",
"ASPARAGINEZUUR, (L-)",
"FENYLALANINE, (L-)",
"GLUTAMINE, (L-)",
"GLYCINE (E 640)",
"HISTIDINE, (L-)",
"ISOLEUCINE, (L-)",
"LEUCINE, (L-) (E 641)",
"LYSINE (L-) 1-WATER",
"LYSINEACETAAT, L-",
"METHIONINE, (L-)",
"PROLINE, (L-)",
"SERINE, (L-)",
"THREONINE, (L-)",
"TRYPTOFAAN, (L-)",
"TYROSINE, (L-)",
"VALINE, (L-)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113028.pdf",
"authorised_at": "2013/06/26",
"procedure_number": "DE/H/0543/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "113028",
"additional_monitoring": "N"
}See everything about aminosäuren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.